A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)

Press/Media

Period	1 Feb 2019

Media coverage

Title	A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)
Media name/outlet	Pharmacy Choice
Country/Territory	United States
Date	1/02/19
URL	www.pharmacychoice.com/news/article.cfm?Article_ID=2180361
Persons	Francisco Espinoza